Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in mice

Endocrinology

Volumn 154, Issue 2, 2013, Pages 718-726

  Kenny, Susan ^a   Gamble, Joanne ^a   Lyons, Suzanne ^a   Vlatković, Nikolina ^a   Dimaline, Rod ^a   Varro, Andrea ^a   Dockray, Graham J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; NEUROPEPTIDE Y2 RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C FOS; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FOOD INTAKE; HELICOBACTER FELIS; HELICOBACTER INFECTION; HYPERPHAGIA; MALE; MOUSE; NERVE CELL CULTURE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REFEEDING; SATIETY; SENSORY NERVE; SOLITARY TRACT NUCLEUS; STOMACH PARIETAL CELL; VAGUS NERVE;

ANIMALS; CHOLECYSTOKININ; HELICOBACTER FELIS; HELICOBACTER INFECTIONS; HYPERPHAGIA; MICE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SATIATION; STOMACH;

EID: 84872717790     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1913     Document Type: Article

References (45)

1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661-671. (Pubitemid 30205071)
2. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117:13-23. (Pubitemid 46048445)
3. Kenny S, Duval C, Sammut SJ, et al. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2008;295:G431-G441.
4. Keates AC, Tummala S, Peek RM Jr, et al. Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun. 2008;76:3992-3999.
5. Landin K, Stigendal L, Eriksson E, et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism. 1990;39:1044-1048. (Pubitemid 20351262)
6. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. 1996;2:800-803. (Pubitemid 26225097)
7. Norsett KG, Steele I, Duval C, et al. Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;301:G446-G453.
8. Dockray GJ. The versatility of the vagus. Physiol Behav. 2009;97:531-536.
9. Raybould HE. Gut chemosensing: interactions between gut endocrine cells and visceral afferents. Auton Neurosci. 2010;153:41-46.
10. Wang YH, Tache Y, Sheibel AB, Go VL, Wei JY. Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. Am J Physiol. 1997;273:R833-R837. (Pubitemid 27428104)
11. de Lartigue G, Lur G, Dimaline R, Varro A, Raybould H, Dockray GJ. EGR1 is a target for cooperative interactions between cholecystokinin and leptin, and inhibition by ghrelin, in vagal afferent neurons. Endocrinology. 2010;151:3589-3599.
12. Peters JH, Karpiel AB, Ritter RC, Simasko SM. Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin. Endocrinology. 2004;145:3652-3657. (Pubitemid 39037550)
13. Date Y, Toshinai K, Koda S, et al. Peripheral interaction of ghrelin with cholecystokinin on feeding regulation. Endocrinology. 2005;146:3518-3525. (Pubitemid 41058123)
14. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 1998;18:9471-9479. (Pubitemid 28512476)
15. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med. 2005;202:1023-1029. (Pubitemid 41464495)
16. Gaige S, Abou E, Abysique A, Bouvier M. Effects of interactions between interleukin-1β and leptin on cat intestinal vagal mechanoreceptors. J Physiol. 2004;555:297-310. (Pubitemid 38313078)
17. Lorenz RG, Gordon JI. Use of transgenic mice to study regulation of gene expression in the parietal cell lineage of gastric units. J Biol Chem. 1993;268:26559-26570. (Pubitemid 23361736)
18. Berkenpas MB, Lawrence DA, Ginsburg D. Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J. 1995;14:2969-2977.
19. Dockray GJ, Hamer C, Evans D, Varro A, Dimaline R. The secretory kinetics of the G cell in omeprazole-treated rats. Gastroenterology. 1991;100:1187-1194.
20. McLaughlin J, Grazia LM, Jones MN, D'Amato M, Dockray GJ, Thompson DG. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology. 1999;116:46-53. (Pubitemid 29013492)
21. Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 2005;65:10709-10715. (Pubitemid 41713338)
22. de Lartigue G, Dimaline R, Varro A, Dockray GJ. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J Neurosci. 2007;27:2876-2882. (Pubitemid 46438967)
23. Burdyga G, de Lartigue G, Raybould HE, et al. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J Neurosci. 2008;28:11583-11592.
24. De Taeye BM, Novitskaya T, Gleaves L, Covington JW, Vaughan DE. Bone marrow plasminogen activator inhibitor-1 influences the development of obesity. J Biol Chem. 2006;281:32796-32805. (Pubitemid 46036835)
25. Nordstrom SM, Carleton SM, Carson WL, Eren M, Phillips CL, Vaughan DE. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Bone. 2007;41:995-1004. (Pubitemid 350116743)
26. Lijnen HR, Maquoi E, Morange P, et al. Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol. 2003;23:78-84. (Pubitemid 36091629)
27. Lijnen HR, Van HB, Umans K, Collen D. Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1). J Thromb Haemost. 2004;2:16-22. (Pubitemid 40185614)
28. Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR. Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature. 1990;346:74-76.
29. Lijnen HR. Murine models of obesity and hormonal therapy. Thromb Res 2011;127(Suppl)3:S17-S20.
30. Alessi MC, Poggi M, Juhan-Vague I. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol. 2007;18:240-245. (Pubitemid 46743045)
31. Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA. 1997;94:10455-10460. (Pubitemid 27407063)
32. Daly DM, Park SJ, Valinsky WC, Beyak MJ. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol. 2011;589:2857-2870.
33. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1423-R1439.
34. Hayes MR, Skibicka KP, Leichner TM, et al. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab. 2010;11:77-83.
35. de Lartigue G, Barbier dlS, Espero E, Lee J, Raybould HE. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. Am J Physiol Endocrinol Metab. 2011;301:E187-E195.
36. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 2002;123:1120-1128.
37. Burdyga G, Varro A, Dimaline R, Thompson DG, Dockray GJ. Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance. Am J Physiology Gastrointest Liver Physiol. 2006;290:G1289-G1297. (Pubitemid 43788312)
38. Zhao TJ, Liang G, Li RL, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci U S A. 2010;107:7467-7472.
39. Chuang JC, Perello M, Sakata I, et al. Ghrelin mediates stress-induced food-reward behavior in mice. J Clin Invest. 2011;121:2684-2692.
40. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003-2014.
41. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327-336.
42. + T lymphocytes during small intestinal inflammation. Gut. 2006;55:492-497.
43. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest. 2011;121:2126-2132.
44. Bercik P, Verdu EF, Foster JA, et al. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol. 2009;296:R587-R594.
45. Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels: a systematic review. BMC Gastroenterol. 2011;11:7.